$BBIO 3 SEC Filings

Filed On	Filing
18 Aug 2025	Form 3: BridgeBio Pharma Llc, 10% owner and 1 other · BridgeBio Oncology Therapeutics Inc Holds 13,805,126 shares of Common Stock
27 Feb 2025	Form 3: Apuli Maricel, Chief Accounting Officer Holds 125,005 shares of Common Stock
29 Jul 2024	Form 3: Trimarchi Thomas, President and COO Holds 394,856 shares of Common Stock
28 Feb 2023	Form 3: Mccormick Frank, Director Holds 1,200,065 shares of Common Stock
26 Oct 2021	Form 3: Valantine Hannah, Director No securities owned
26 Aug 2021	Form 3: Ellis Andrea, Director No securities owned
26 Aug 2021	Form 3: Dachille Douglas A., Director No securities owned
26 Aug 2021	Form 3: Hassan Fred, Director No securities owned
25 Jun 2020	Form 3: Saunders Brent L, Director No securities owned
25 Jun 2020	Form 3: Scott Randal W, Director Holds 5,000 shares of Common Stock
25 Jun 2020	Form 3: Lo Andrew, Director Holds 40,599 shares of Common Stock
14 Feb 2020	Form 3: Daniels Ronald J, Director No securities owned
03 Jan 2020	Form 3: Kkr Group Partnership L.p., 10% owner Holds 36,900,661 shares of Common Stock
16 Dec 2019	Form 3: Cook Jennifer E., Director
15 Nov 2019	Form 3: Stolz Brian M., Chief Operating Officer No securities owned
15 Nov 2019	Form 3: Yau Yi Ching, Chief Accounting Officer No securities owned
27 Jun 2019	Form 3: Viking Global Investors Lp, 10% owner and 6 others
27 Jun 2019	Form 3: Turtle Cameron, See Remarks
27 Jun 2019	Form 3: Scheller Richard H, Director Holds 0 shares of No securities beneficially owned.
27 Jun 2019	Form 3: Momtazee James C, Director No securities owned

Comments